sydneysider
there's "grade" and "head grade"
i think the grades are fine - it's the head grades that are low right now.
that's because CTO is "Developing ahead of Production".
During the current development stage the overall ore mix may be say 60% development ore /40% stoped ore right now.
Once the Development is advanced and more and more stopes are producing the overall ore mix might switch around to say 60% stoped /40% development.
The stoped ore percentage rising from the current 40% to 60% later on represents a 50% rise in head grades - a very significant shift.
There will always be a level of dilution - it's just that it's excessive in this early development stage.
what is remarkable is that given the current level of dilution and low production rate the costs are under Aus $500/oz (US$350/oz).
so the costs should come down significantly with an increased production rate (scale) and a 50% rise in head grades.
i think cost estimates of under $350/oz sounds right.
We just need to see production and more stopes... and until we do it's just theory and idle talk.
- Forums
- ASX - By Stock
- CTO
- will cto get whipped today?
will cto get whipped today?, page-23
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTO (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $204 | 51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6088 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 7200936 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6088 | 0.004 |
28 | 17575269 | 0.003 |
11 | 17478693 | 0.002 |
10 | 15702988 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 7200936 | 16 |
0.006 | 5417960 | 8 |
0.007 | 2263000 | 4 |
0.008 | 5922992 | 6 |
0.009 | 2370800 | 4 |
Last trade - 13.32pm 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
CTO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online